Preise & Rabatte einsehen
Geschenke sichern
Angebote anfragen & online annehmen
Mesothelioma
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — FITC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 50 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — PE - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified (PhenoCyler-Fusion (CODEX)® Ready) - 50 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — Purified (PhenoCyler-Fusion (CODEX)® Ready) - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 5.0 mg | Anmelden | Anti-Human CD276 (B7-H3) (Mirzotamab) - 5.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 1.0 mg | Anmelden | Anti-Human CD276 (B7-H3) (Mirzotamab) - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) – Fc Muted™ - 500 µg | Anmelden | Anti-Human CD276 (B7-H3) (Mirzotamab) – Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 25 mg | Anmelden | Anti-Human CD276 (B7-H3) (Mirzotamab) - 25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 50 mg | Anmelden | Anti-Human CD276 (B7-H3) (Mirzotamab) - 50 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD276 (B7-H3) (Mirzotamab) - 100 mg | Anmelden | Anti-Human CD276 (B7-H3) (Mirzotamab) - 100 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 488 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 594 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 100 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 200 µg | Anmelden | Anti-Human HLA-A, B, C (MHC Class I) [W6/32] — DyLight® 650 - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 1 mg | Anmelden | Anti-Human EGFR x MET (Amivantamab) - 1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 100 mg | Anmelden | Anti-Human EGFR x MET (Amivantamab) - 100 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 25 mg | Anmelden | Anti-Human EGFR x MET (Amivantamab) - 25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 50 mg | Anmelden | Anti-Human EGFR x MET (Amivantamab) - 50 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) - 5 mg | Anmelden | Anti-Human EGFR x MET (Amivantamab) - 5 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR x MET (Amivantamab) – Fc Muted™ - 500 µg | Anmelden | Anti-Human EGFR x MET (Amivantamab) – Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||
